Medicare Enrolled

Dr. Nehal Gandhi, MD

Rheumatology · Glen Mills, PA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
30 LACRUE AVE STE 101, Glen Mills, PA 19342
6105584800
Registered in NPPES since 2008
NPI: 1295909919 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gandhi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gandhi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gandhi

Dr. Nehal Gandhi is a rheumatology specialist in Glen Mills, PA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Gandhi performed 902,194 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Gandhi received a total of $3,905 from 15 pharmaceutical and/or device companies across 123 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gandhi is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years of NPI registration ▲ Top 0% volume in PA $3,905 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
902,194
Medicare services
Top 0% in PA for rheumatology
Not available
Unique patients (not deduplicated)
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
507,600 $4 $16
Tocilizumab injection (Actemra) 166,830 $5 $10
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
72,575 $34 $99
Golimumab infusion (Simponi Aria)
Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery.
57,850 $10 $60
Infliximab infusion (Remicade)
An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose.
29,090 $25 $118
Romosozumab injection (Evenity) for osteoporosis 22,470 $8 $25
Denosumab injection (Prolia/Xgeva) 20,040 $18 $39
Joint lubricant injection (TriVisc)
An injection of hyaluronan or a derivative into a joint space. The dose specified is 1 milligram.
7,575 $7 $32
Infliximab-abda biosimilar injection, 10 mg
This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product.
6,750 $30 $123
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
3,089 $62 $204
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
2,712 $1 $15
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
2,197 $106 $370
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,931 $100 $287
Additional hour of intravenous chemotherapy
This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period.
612 $23 $110
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
426 $63 $244
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
171 $127 $441
Methylprednisolone injection, up to 125 mg
An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg.
84 $4 $60
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
83 $11 $68
Joint fluid aspiration or injection, small joint
Removal of fluid from a small joint or injection of medication into a small joint.
41 $38 $205
Joint fluid aspiration or injection, medium joint
Removal of fluid from a medium-sized joint or injection of medication into the joint space.
26 $37 $145
Diphenhydramine injection, up to 50 mg
An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams.
24 $1 $20
Tendon or ligament injection
A procedure involving the injection of medication into a tendon or ligament.
18 $40 $159
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
17.9% high complexity
81.8% medium
0.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$3,905
Total received (2018-2024)
Avg $558/year across 7 years
Top 44% in PA for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
15
Companies
123
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$535
2023
$551
2022
$474
2021
$1,691
2020
$20
2019
$137
2018
$498

Payments by company (2024)

UCB, Inc.
$144
Janssen Biotech, Inc.
$138
ABBVIE INC.
$137
Mallinckrodt Hospital Products Inc.
$68
ANI Pharmaceuticals, Inc.
$27
Lilly USA, LLC
$21
Top 3 companies account for 78.3% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,570
Janssen Biotech, Inc.
$567
ABBVIE INC.
$404
Mallinckrodt Hospital Products Inc.
$310
Amgen Inc.
$251
Lilly USA, LLC
$186
UCB, Inc.
$144
PFIZER INC.
$142
ANI Pharmaceuticals, Inc.
$117
SANOFI-AVENTIS U.S. LLC
$100
E.R. Squibb & Sons, L.L.C.
$43
AbbVie Inc.
$24
Horizon Therapeutics plc
$18
Fresenius Kabi USA, LLC
$16
Horizon Pharma plc
$12
Top 3 companies account for 65.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AVSOLA · Bimzelx · COSENTYX · Cimzia · DUEXIS · EVENITY · Enbrel · FORTEO · IDACIO · KEVZARA · KRYSTEXXA · ORENCIA · PURIFIED CORTROPHIN GEL · RINVOQ · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TREMFYA · Tavneos · XELJANZ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Glen Mills?
Compare rheumatologists in the Glen Mills area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
129
County median income
$88,576
Nearest hospital to ZIP centroid (approximate)
RIDDLE MEMORIAL HOSPITAL
4.7 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gandhi is a mixed practice specialist, with above-average Medicare volume (top 0% in PA), with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gandhi experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Gandhi performed 507,600 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gandhi receive payments from pharmaceutical companies?
Yes. Dr. Gandhi received a total of $3,905 from 15 companies across 123 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gandhi's costs compare to other rheumatologists in Glen Mills?
Dr. Gandhi's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gandhi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →